Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

AstraZeneca PLC (AZN) Institutional Ownership & Insider Trading

1,467 institutions reported holding AstraZeneca PLC shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AZNAstraZeneca PLCFollow AZN — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
274.1B
P/E TTM
25.7
Dividend yield
—
52-week
—
Next earnings
30 Oct, in 6 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,467 institutions held 50.3% of the shares. Across filers that reported both quarters, shares held changed +2.4%.

Increased+444New+235Decreased-394Closed-88

Largest moves, shares (millions)

Wellington Management Group+4.8MDimensional Fund Advisors+2.9MCauseway Capital Management+1.9MT. Rowe Price Associates-2.9MNational Bank of Canada-1.7MBank of America-1.4M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.1Sep 24-0.0Dec 24-0.0Mar 25+0.0Jun 25+0.1Sep 25+0.0Dec 25+0.0Mar 26+17.6Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 261,467804+2.4%44423539488
Mar 261,308748—————
Dec 25461—————
Sep 2520—2000
Jun 2530—0110
Mar 2520—0010
Dec 2420—0011
Sep 2430—0111

AstraZeneca PLC — questions

Who owns AstraZeneca PLC stock?
1,467 institutions reported AstraZeneca PLC shares in 13F filings for the quarter ended 2026-06-30. The largest: INVESTOR AB (3.2%), VANGUARD CAPITAL MANAGEMENT LLC (2.8%), Capital International Investors (2.2%).
Are AstraZeneca PLC insiders buying or selling?
2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from AstraZeneca PLC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.